Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

API Manufacturing: SOP for QA Role in Cleaning Validation – V 2.0

Posted on By

API Manufacturing: SOP for QA Role in Cleaning Validation – V 2.0

Standard Operating Procedure for QA Role in Cleaning Validation in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/198/2025
Supersedes SOP/API/198/2022
Page No. Page 1 of 15
Issue Date 14/04/2025
Effective Date 16/04/2025
Review Date 14/04/2026

1. Purpose

To define the role of the Quality Assurance (QA) department in planning, executing, reviewing, and approving cleaning validation activities in API manufacturing to ensure the effectiveness of cleaning processes and compliance with regulatory standards.

2. Scope

This SOP applies to the QA team involved in cleaning validation activities for equipment, utensils, reactors, and contact

surfaces used in the production of Active Pharmaceutical Ingredients (APIs). It covers cleaning validation protocol review, sample plan approval, result assessment, and final validation report authorization.

3. Responsibilities

  • QA Executive: Coordinates validation activities, witnesses sampling, and verifies documentation.
  • QA Manager: Reviews and approves validation protocols, final reports, and deviation justifications.
  • QA Analyst: Ensures adherence to sample plan and maintains records of test results.

See also  API Manufacturing: SOP for Issuance of Controlled Copies of SOPs - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring all cleaning validation activities are compliant with cGMP, properly documented, and aligned with applicable guidelines.

5. Procedure

5.1 Cleaning Validation Plan Review

  1. QA shall review the Annual Cleaning Validation Master Plan (CVMP) (Annexure-1) to ensure it includes:
    • List of equipment and products covered
    • Selection criteria for worst-case product
    • Sampling locations and limits
    • Acceptance criteria and revalidation frequency

5.2 Protocol Review and Approval

  1. QA shall ensure cleaning validation protocols include:
    • Objective and scope
    • Sampling and test method details
    • Acceptance limits (e.g., MACO calculations)
    • Recovery factor validations
  2. All protocols must be reviewed for accuracy, feasibility, and regulatory compliance before final QA approval (Annexure-2).

5.3 Pre-Validation Activities

  1. QA shall:
    • Ensure cleaning procedures and materials (detergents, rinse media) are validated
    • Check equipment status (line clearance, batch records)
    • Verify availability of qualified personnel for sample collection

5.4 Sample Plan Approval and Witnessing

  1. QA shall review and sign the Cleaning Validation Sample Plan (Annexure-3), confirming:
    • Swab and rinse sampling locations
    • Number of samples per equipment surface
    • Sample container labeling and documentation
  2. QA must witness sample collection or review the sample transfer logs immediately post-collection.

5.5 Test Result Review and Trend Analysis

  1. QA shall evaluate test results for:
    • Residue levels (µg/swab or ppm)
    • Microbial contamination
    • Cleaning agent residuals (where applicable)
  2. Results shall be trended using the Cleaning Validation Results Log (Annexure-4) to detect any deviations or inconsistencies.
See also  API Manufacturing: SOP for Emergency Handling in Solvent Area - V 2.0

5.6 Deviations and Investigation

  1. If acceptance criteria are not met:
    • QA shall initiate a deviation report
    • Conduct root cause analysis
    • Approve additional cleaning and re-sampling
  2. All deviations must be addressed before final report approval.

5.7 Approval of Final Cleaning Validation Report

  1. QA Manager shall review:
    • Protocol adherence
    • Test results and acceptance
    • Deviations and CAPAs (if any)
  2. QA shall approve the Cleaning Validation Summary Report (Annexure-5) and archive all related records.

5.8 Revalidation Criteria

  1. QA shall initiate revalidation in cases of:
    • Product change or new product introduction
    • Equipment modification or relocation
    • Change in cleaning procedure or material

6. Abbreviations

  • QA: Quality Assurance
  • CVMP: Cleaning Validation Master Plan
  • SOP: Standard Operating Procedure
  • MACO: Maximum Allowable Carryover
  • cGMP: current Good Manufacturing Practice

7. Documents

  1. Cleaning Validation Master Plan (CVMP) – Annexure-1
  2. Cleaning Validation Protocol Review Form – Annexure-2
  3. Cleaning Validation Sample Plan – Annexure-3
  4. Cleaning Validation Results Log – Annexure-4
  5. Cleaning Validation Summary Report – Annexure-5

See also  API Manufacturing: SOP for Solvent Transfer Using Pumps - V 2.0

8. References

  • ICH Q7 – Good Manufacturing Practice for Active Pharmaceutical Ingredients
  • FDA Guidance for Industry: Cleaning Validation (2001)
  • EU GMP Annex 15 – Qualification and Validation
  • WHO TRS 937 Annex 4 – GMP Guidelines for APIs

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Cleaning Validation Master Plan

Equipment Worst-Case Product Sampling Points Validation Frequency
Reactor R-101 Product X 3 Swab Points Annual

Annexure-2: Cleaning Validation Protocol Review Form

Protocol No. Reviewed By Date Comments
CVP-025 QA Manager 10/04/2025 Compliant

Annexure-3: Cleaning Validation Sample Plan

Equipment Location Sample Type Sample ID
Dryer D-02 Outlet Valve Swab CVS-1001

Annexure-4: Cleaning Validation Results Log

Sample ID Residue Level Limit Status Analyst
CVS-1001 2.3 µg ≤ 10 µg Pass Sunita Reddy

Annexure-5: Cleaning Validation Summary Report

Report No. Equipment Validated On Approved By Status
CVSR-025 Dryer D-02 12/04/2025 QA Head Approved

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial Issue New SOP QA Head
14/04/2025 2.0 Updated roles and annexure format Audit Observation QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Gel Manufacturing: SOP for Secondary Packaging of Gel Products – V 2.0
Next Post: Elixir Department: SOP for Line Clearance After Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version